201 related articles for article (PubMed ID: 23270420)
41. Relationship between
Lozano-Tovar S; Rodríguez-Agudelo Y; Dávila-Ortiz de Montellano DJ; Pérez-Aldana BE; Ortega-Vázquez A; Monroy-Jaramillo N
Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901420
[TBL] [Abstract][Full Text] [Related]
42. Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease.
Yokoyama JS; Bonham LW; Sears RL; Klein E; Karydas A; Kramer JH; Miller BL; Coppola G
BMC Neurol; 2015 Mar; 15():47. PubMed ID: 25880661
[TBL] [Abstract][Full Text] [Related]
43. Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.
Connors MH; Ames D; Woodward M; Brodaty H
Am J Geriatr Psychiatry; 2018 Mar; 26(3):304-313. PubMed ID: 29174998
[TBL] [Abstract][Full Text] [Related]
44. Genetics of neuropsychiatric symptoms in patients with Alzheimer's disease: A 1-year follow-up study.
Huang MF; Lee WJ; Yeh YC; Liao YC; Wang SJ; Yang YH; Chen CS; Fuh JL
Psychiatry Clin Neurosci; 2020 Dec; 74(12):645-651. PubMed ID: 32909371
[TBL] [Abstract][Full Text] [Related]
45. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
46. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
47. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
[TBL] [Abstract][Full Text] [Related]
48. Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
Jiang J; Hong Y; Li W; Wang A; Jiang S; Jiang T; Wang Y; Wang L; Yang S; Ren Q; Zou X; Xu J
J Alzheimers Dis; 2023; 96(2):669-681. PubMed ID: 37840496
[TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
50. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.
Haasl RJ; Ahmadi MR; Meethal SV; Gleason CE; Johnson SC; Asthana S; Bowen RL; Atwood CS
BMC Med Genet; 2008 Apr; 9():37. PubMed ID: 18439297
[TBL] [Abstract][Full Text] [Related]
51. Incidence of and risk factors for hallucinations and delusions in patients with probable AD.
Paulsen JS; Salmon DP; Thal LJ; Romero R; Weisstein-Jenkins C; Galasko D; Hofstetter CR; Thomas R; Grant I; Jeste DV
Neurology; 2000 May; 54(10):1965-71. PubMed ID: 10822438
[TBL] [Abstract][Full Text] [Related]
52. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
53. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
54. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.
Drigalenko E; Poduslo S; Elston R
Neurology; 1998 Jul; 51(1):131-5. PubMed ID: 9674791
[TBL] [Abstract][Full Text] [Related]
55. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.
Holmes C; Smith H; Ganderton R; Arranz M; Collier D; Powell J; Lovestone S
J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):777-9. PubMed ID: 11723200
[TBL] [Abstract][Full Text] [Related]
56. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
[TBL] [Abstract][Full Text] [Related]
58. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
Hallikainen I; Hongisto K; Välimäki T; Hänninen T; Martikainen J; Koivisto AM
J Alzheimers Dis; 2018; 61(4):1367-1376. PubMed ID: 29376861
[TBL] [Abstract][Full Text] [Related]
59. Association of apolipoproteins e4 and c1 with onset age and memory: a study of sporadic Alzheimer disease in Taiwan.
Chuang WL; Hsieh YC; Wang CY; Kuo HC; Huang CC
J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):42-8. PubMed ID: 20145290
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease.
Gormley N; Rizwan MR
Int J Geriatr Psychiatry; 1998 Jun; 13(6):410-4. PubMed ID: 9658277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]